BetterLife Obtains TD-0148A Receptor Binding Data for IND-Enabling Pharmacology Studies
29. September 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 29, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders
27. September 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 27, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Enrolls First Patient in Interferon alpha-2b COVID-19 Trial in Chile
22. September 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its wholly owned...
BetterLife to Present at the Emerging Growth Conference on September 15, 2021
13. September 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotechnology company...
BetterLife Enters Research Agreement with Medical College Wisconsin for TD-0148A Neurological Receptor Studies
09. September 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotechnology company...
BetterLife Initiates Preclinical Study of AP-003 (rhIFNa2b) against Delta Variant of SARS-CoV-2
25. August 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Aug. 25, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotechnology company...
BetterLife Receives Approval to Conduct COVID-19 Randomized Placebo-Controlled Trial with Pontificia Universidad Católica de Chile
27. Juli 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 27, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its wholly owned...
BetterLife-Carleton University Research Team Secure Mitacs Accelerate Funding to Study the Therapeutic Effect of TD-010 in Chronic Anxiety
22. Juli 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 22, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on...
BetterLife to Present at the Emerging Growth Conference
19. Juli 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 19, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:NPAU ), an emerging biotechnology company...
Early Results of BetterLife Preclinical Study Showing AP-003 (rhIFNa2b) has Similar Potent Efficacy Against Different Variants of COVID-19
15. Juli 2021 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 15, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotechnology company...